Scarica l'app Stockscreener
77.36
0.86%
0.66
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie
How rising interest rates impact ANI Pharmaceuticals Inc. stockJuly 2025 Drop Watch & Technical Buy Zone Confirmation - mfd.ru
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ET - The Manila Times
ANI Pharmaceuticals, Inc. to Release Q4 and Full Year 2025 Financial Results on February 27, 2026 - Quiver Quantitative
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ET - GlobeNewswire Inc.
Principal Financial Group Inc. Lowers Stake in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Is ANI Pharmaceuticals Inc. stock a good choice for value investors2025 Sector Review & Free Risk Controlled Daily Trade Plans - mfd.ru
Aug Wrap: Will ANI Pharmaceuticals Inc stock go up in YEARMarket Trend Summary & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
What is the Moat Score of ANI Pharmaceuticals Inc.July 2025 Spike Watch & Risk Controlled Swing Trade Alerts - mfd.ru
Investors Don't See Light At End Of ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Tunnel - 富途牛牛
Is ANI Pharmaceuticals (ANIP) Pricing Reflect Long Term Value After Strong Multi Year Returns - Yahoo Finance
Thrivent Financial for Lutherans Has $5.32 Million Stake in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Ranger Investment Management L.P. Decreases Stock Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Is ANI Pharmaceuticals (ANIP) a Great Value Stock Right Now? - Yahoo Finance
Is ANI Pharmaceuticals (ANIP) Pricing Reflect Long Term Cash Flow Potential? - Sahm
ANI Pharmaceuticals Pivots to High-Value Rare Disease Treatments - AD HOC NEWS
ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A Promising 37.97% Upside Awaits Investors - DirectorsTalk Interviews
ANI Pharmaceuticals, Inc. $ANIP is Lisanti Capital Growth LLC's 5th Largest Position - MarketBeat
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Did 53.60% Revenue Growth and Portfolio Expansion Just Shift ANI Pharmaceuticals' (ANIP) Investment Narrative? - Sahm
Trading Action: Is ANI Pharmaceuticals Inc exposed to political riskJuly 2025 Gainers & Reliable Volume Spike Alerts - baoquankhu1.vn
ANI Pharmaceuticals (ANIP) Stock Analysis: Exploring A 35.71% Potential Upside - DirectorsTalk Interviews
Implied Volatility Surging for ANI Pharmaceuticals Stock Options - Yahoo Finance
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Passes Below Fifty Day Moving AverageHere's What Happened - MarketBeat
40 Under 40: Kevin Chan, ANI Pharmaceuticals - Medical Marketing and Media
ANI Pharmaceuticals, Inc. (ANIP): Investor Outlook With A Promising 30% Upside Potential - DirectorsTalk Interviews
Breakout Move: Does ANI Pharmaceuticals Inc stock have upside surprise potential - baoquankhu1.vn
ANI Pharmaceuticals, Inc. $ANIP Shares Sold by Mizuho Markets Americas LLC - MarketBeat
Aug Setups: What is the next catalyst for SEALPRAQuarterly Earnings Report & Technical Pattern Based Signals - baoquankhu1.vn
Campbell & CO Investment Adviser LLC Invests $1.60 Million in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (ANIP) Is Up 11.2% After Raising 2026 Revenue Outlook And Rare Disease Hiring Plan – Has The Bull Case Changed? - Sahm
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
ANIP vs. TEVA: Which Drug Stock Is the Better Buy Right Now? - Eastern Progress
ANIP Stock Rises 7% in a Week: Here's What You Should Know - Eastern Progress
Guggenheim Reaffirms Their Buy Rating on ANI Pharmaceuticals (ANIP) - The Globe and Mail
SG Americas Securities LLC Boosts Stock Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (ANIP) Is Up 7.0% After Raising 2026 Revenue Outlook and Expanding Rare Disease Team - Yahoo Finance
Insider Sell Alert: Meredith Cook Sells Shares of ANI Pharmaceuticals Inc (ANIP) - GuruFocus
Ani Pharmaceuticals’ Cook sells $42,165 in stock By Investing.com - Investing.com Australia
Insider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) VP Sells 500 Shares of Stock - MarketBeat
Ani Pharmaceuticals’ Cook sells $42,165 in stock - Investing.com
ANI Pharmaceuticals Targets $1B+ 2026 Revenue as Rare Disease Pivot Accelerates, Cortrophin Leads Growth - Yahoo Finance
ANI Pharmaceuticals (ANIP) Stock Dips on Profit-Taking After 2026 GuidanceNews and Statistics - IndexBox
ANI Pharmaceuticals (ANIP) Stock Trades Down, Here Is Why - Finviz
Dow Theory LettersANI Pharmaceuticals (ANIP) Stock Trades Down, Here Is Why - FinancialContent
ANI Pharmaceuticals: Strong 2025 Finish And Bullish 2026 Guidance (NASDAQ:ANIP) - Seeking Alpha
Stocks making big moves yesterday: OneMain, Nextpower, ANI Pharmaceuticals, Akamai Technologies, and Lemonade - The Globe and Mail
Growth Review: Can ANI Pharmaceuticals Inc. stock deliver consistent earnings growth2025 Performance Recap & Stepwise Trade Signal Implementation - Bộ Nội Vụ
Fund Flows: Why ANI Pharmaceuticals Inc stock remains undervaluedEarnings Risk Summary & Low Risk Entry Point Guides - Bộ Nội Vụ
ANI Pharmaceuticals, Inc. (ANIP) Investor Outlook: Exploring a 29.52% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Decker Retirement Planning Inc. Boosts Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals expects over $1 billion in 2026 revenue By Investing.com - Investing.com Nigeria
Why ANI Pharmaceuticals (ANIP) Stock Is Trading Up Today - Finviz
The Sun: Local News, Sports and Things to DoWhy ANI Pharmaceuticals (ANIP) Stock Is Trading Up Today - FinancialContent
ANI Pharmaceuticals (NASDAQ:ANIP) Shares Gap UpTime to Buy? - MarketBeat
Ani Pharmaceuticals, Inc. Provides Revenue Guidance for the Full Year 2026 - marketscreener.com
1.19%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):